Opus Genetics, Inc. is a clinical-stage ophthalmic biopharmaceutical company. The Company focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs) and other retinal and refractive disorders. Opus Genetics serves customers worldwide.
more
Refresh
No presentations found
We’ll display presentations we find for Opus Genetics here